Found: 45
Select item for more details and to access through your institution.
Complimentary Role of [18F]FDG and [18F]NaF-PET/CT in Evaluating Synchronous Thyroid Carcinoma and Parathyroid Adenoma with Brown Tumors.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Unusual Metastatic Sites and Radioiodine Uptake in Patients of Differentiated Thyroid Carcinoma with Atypical Clinical Presentations: Utilization of <sup>131</sup> I-Whole-Body Scintigraphy with Regional SPECT/CT.
- Published in:
- World Journal of Nuclear Medicine, 2024, v. 23, n. 2, p. 130, doi. 10.1055/s-0044-1779750
- By:
- Publication type:
- Article
Unusual Metastatic Sites of Testis and Rectum in Prostate Cancer Detected by <sup>68</sup> Ga-PSMA-11 PET/CT Imaging at Initial Staging.
- Published in:
- World Journal of Nuclear Medicine, 2024, v. 23, n. 1, p. 43, doi. 10.1055/s-0044-1778710
- By:
- Publication type:
- Article
Follicular thyroid carcinoma metastasizing to rare sites and exhibiting variable inter-lesional heterogeneity on <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography and <sup>131</sup>I.
- Published in:
- World Journal of Nuclear Medicine, 2021, v. 20, n. 3, p. 312, doi. 10.4103/wjnm.WJNM_79_20
- By:
- Publication type:
- Article
Initial clinical evaluation of indigenous<sup>90</sup>Y-DOTATATE in sequential duo-PRRT approach (<sup>177</sup>Lu-DOTATATE and<sup>90</sup>Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability,<sup>90</sup>Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects
- Published in:
- World Journal of Nuclear Medicine, 2021, v. 20, n. 1, p. 73, doi. 10.4103/wjnm.WJNM_52_20
- By:
- Publication type:
- Article
Clinical efficacy of <sup>177</sup>Lu‑DOTATATE peptide receptor radionuclide therapy in thyroglobulin‑elevated negative iodine scintigraphy: A “not‑so‑promising” result compared to GEP-NETs.
- Published in:
- World Journal of Nuclear Medicine, 2020, v. 19, n. 3, p. 205, doi. 10.4103/wjnm.WJNM_21_19
- By:
- Publication type:
- Article
Prevalence of hitherto unknown brain meningioma detected on <sup>68</sup>Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of<sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors
- Published in:
- World Journal of Nuclear Medicine, 2019, v. 18, n. 2, p. 160, doi. 10.4103/wjnm.WJNM_39_18
- By:
- Publication type:
- Article
Usefulness of Tc99m-mebrofenin Hepatobiliary Scintigraphy and Single Photon Emission Computed Tomography/Computed Tomography in the Diagnosis of Bronchobiliary Fistula.
- Published in:
- World Journal of Nuclear Medicine, 2017, v. 16, n. 4, p. 317, doi. 10.4103/1450-1147.215490
- By:
- Publication type:
- Article
Presentation of Unusual Tracheal Metastasis on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography after 9 Years in Postnephrectomy Patient of Renal Cell Carcinoma: A Case Report and Review of Literature.
- Published in:
- World Journal of Nuclear Medicine, 2017, v. 16, n. 3, p. 240, doi. 10.4103/1450-1147.207280
- By:
- Publication type:
- Article
<sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Metastatic or Advanced and Inoperable Primary Neuroendocrine Tumors of Rare Sites.
- Published in:
- World Journal of Nuclear Medicine, 2017, v. 16, n. 3, p. 223, doi. 10.4103/1450-1147.207283
- By:
- Publication type:
- Article
Failed Radiation Synovectomy in Diseased Knee Joint with Missed Tuberculous Synovitis.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Failed radiation synovectomy in diseased knee joint with missed tuberculous synovitis.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Multiple Brown Tumors Caused by a Parathyroid Adenoma Mimicking Metastatic Bone Disease from Giant Cell Tumor.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Breast Metastasis Detected on Ga-68 DOTATATE Positron Emission Tomography/ Computed Tomography Imaging in Malignant Pheochromocytoma.
- Published in:
- World Journal of Nuclear Medicine, 2015, v. 14, n. 1, p. 69, doi. 10.4103/1450-1147.150563
- By:
- Publication type:
- Article
Prognostic predictors for recurrence following curative resection in grade I/II pancreatic neuroendocrine tumours.
- Published in:
- Langenbeck's Archives of Surgery, 2023, v. 408, n. 1, p. 1, doi. 10.1007/s00423-023-02943-z
- By:
- Publication type:
- Article
Capecitabine-Temozolomide in Advanced Grade 2 and Grade 3 Neuroendocrine Neoplasms: Benefits of Chemotherapy in Neuroendocrine Neoplasms with Significant <sup>18</sup>FDG Uptake.
- Published in:
- Neuroendocrinology, 2021, v. 111, n. 10, p. 998, doi. 10.1159/000511987
- By:
- Publication type:
- Article
Evaluation of Ectopic Kidney Located at the Deep Subcutaneous Region of the Abdominal Wall: Role of Diuretic Renography with <sup>99m</sup>Tc‐DTPA.
- Published in:
- Journal of Nuclear Medicine Technology, 2024, v. 52, n. 2, p. 1, doi. 10.2967/jnmt.124.267908
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT Versus <sup>68</sup>Ga-PSMA-11 PET/CT in Evaluation of Distant Metastatic Disease in Recurrent Renal Cell Carcinoma.
- Published in:
- Journal of Nuclear Medicine Technology, 2023, v. 51, n. 3, p. 261, doi. 10.2967/jnmt.122.264014
- By:
- Publication type:
- Article
False-Positive <sup>68</sup>Ga-DOTATATE PET/CT Findings in Hereditary Hypophosphatemia–Osteomalacia Mimicking Culprit Lesions of Tumor-Induced Osteomalacia.
- Published in:
- Journal of Nuclear Medicine Technology, 2023, v. 51, n. 1, p. 73, doi. 10.2967/jnmt.121.263776
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT vs. <sup>68</sup>Ga-PSMA-11 PET/CT in evaluation of distant metastatic disease in recurrent Renal Cell Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
False positive <sup>68</sup>Ga-DOTATATE PET-CT in Hereditary hypophosphatemic-osteomalacia mimicking culprit lesions of tumor induced osteomalacia.
- Published in:
- Journal of Nuclear Medicine Technology, 2022, v. 50, n. 3, p. 1, doi. 10.2967/jnmt.121.263776
- By:
- Publication type:
- Article
False positive <sup>68</sup>Ga-DOTATATE PET-CT in Hereditary hypophosphatemic-osteomalacia mimicking culprit lesions of tumor induced osteomalacia.
- Published in:
- Journal of Nuclear Medicine Technology, 2022, v. 50, n. 2, p. 1, doi. 10.2967/jnmt.121.263776
- By:
- Publication type:
- Article
False positive <sup>68</sup>Ga-DOTATATE PET-CT in Hereditary hypophosphatemic-osteomalacia mimicking culprit lesions of tumor induced osteomalacia.
- Published in:
- Journal of Nuclear Medicine Technology, 2022, v. 50, n. 1, p. 1, doi. 10.2967/jnmt.121.263776
- By:
- Publication type:
- Article
Bilateral Orbital Soft-Tissue Metastases from Renal Neuroendocrine Tumor: Successful Theranostic Application of <sup>68</sup>Ga/<sup>177</sup>Lu-DOTATATE with Improvement of Vision.
- Published in:
- Journal of Nuclear Medicine Technology, 2019, v. 47, n. 2, p. 171, doi. 10.2967/jnmt.118.217455
- By:
- Publication type:
- Article
Small Cell Transformation of Metastatic Prostate Adenocarcinoma Diagnosed by Dual-Tracer PET/CT (<sup>68</sup>Ga-PSMA and <sup>18</sup>F-FDG): Potential Clinical Utility in Therapeutic Decision Making and Treatment Monitoring.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Role of <sup>99m</sup>Tc-Methylene Diphosphonate SPECT/CT in the Detection of Sacroiliitis in Patients with Spondyloarthropathy: Comparison with Clinical Markers and MRI.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Grouping of Metastatic Thyroid Carcinoma by Molecular Imaging Features to Allow for Individualized Treatment, with Emphasis on the TENIS Syndrome.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Primary squamous cell carcinoma of pancreas mimicking walled-off pancreatic necrosis.
- Published in:
- Journal of Digestive Endoscopy, 2016, v. 7, n. 1, p. 17, doi. 10.4103/0976-5042.180094
- By:
- Publication type:
- Article
Surgical feasibility, Determinants and overall Efficacy assessment of Neoadjuvant PRRT with <sup>177</sup>Lu-DOTATATE for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258772
- By:
- Publication type:
- Article
Surgical feasibility, Determinants and overall Efficacy assessment of Neoadjuvant PRRT with <sup>177</sup>Lu-DOTATATE for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258772
- By:
- Publication type:
- Article
Surgical feasibility, Determinants and overall Efficacy assessment of Neoadjuvant PRRT with <sup>177</sup>Lu-DOTATATE for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258772
- By:
- Publication type:
- Article
Surgical feasibility, Determinants and overall Efficacy assessment of Neoadjuvant PRRT with <sup>177</sup>Lu-DOTATATE for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258772
- By:
- Publication type:
- Article
Surgical feasibility, Determinants and overall Efficacy assessment of Neoadjuvant PRRT with <sup>177</sup>Lu-DOTATATE for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258772
- By:
- Publication type:
- Article
Surgical feasibility, Determinants and overall Efficacy assessment of Neoadjuvant PRRT with <sup>177</sup>Lu-DOTATATE for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.258772
- By:
- Publication type:
- Article
Surgical feasibility, Determinants and overall Efficacy assessment of Neoadjuvant PRRT with <sup>177</sup>Lu-DOTATATE for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.258772
- By:
- Publication type:
- Article
Surgical feasibility, Determinants and overall Efficacy assessment of Neoadjuvant PRRT with <sup>177</sup>Lu-DOTATATE for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.258772
- By:
- Publication type:
- Article
<sup>131</sup>I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical utility of <sup>177</sup>Lu‐DOTATATE PRRT in somatostatin receptor‐positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity.
- Published in:
- Head & Neck, 2020, v. 42, n. 3, p. 401, doi. 10.1002/hed.26024
- By:
- Publication type:
- Article
Combined <sup>177</sup>Lu‐PSMA‐617 PRLT and abiraterone acetate versus <sup>177</sup>Lu‐PSMA‐617 PRLT monotherapy in metastatic castration‐resistant prostate cancer: An observational study comparing the response and durability
- Published in:
- Prostate, 2021, v. 81, n. 15, p. 1225, doi. 10.1002/pros.24219
- By:
- Publication type:
- Article
Imaging Recommendations for Theranostic PET-CT in Oncology.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2023, v. 44, n. 3, p. 314, doi. 10.1055/s-0042-1760310
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy in the Management of Neuroendocrine Tumors (Neoplasms)*: Fundamentals and Salient Clinical Practice Points for Medical Oncologists.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2019, v. 40, n. 2, p. 165, doi. 10.4103/ijmpo.ijmpo_161_19
- By:
- Publication type:
- Article
Primary autoimmune thrombocytopenia and co-existing Graves' disease: Role of radioiodine-131.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Long-term outcome of "Sandwich" chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive disease.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 3, p. 913, doi. 10.1007/s00259-020-05004-5
- By:
- Publication type:
- Article
Towards personalizing treatment strategies in mCRPC: can dual-tracer PET-CT provide insights into tumor biology, guide the optimal treatment sequence, and individualize decision-making (between chemotherapy, second-generation anti-androgens and PSMA-directed radioligand therapy) early in the disease course?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Availability of both [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTATATE as PRRT agents for neuroendocrine tumors: can we evolve a rational sequential duo-PRRT protocol for large volume resistant tumors?
- Published in:
- 2020
- By:
- Publication type:
- Letter